Bioventus Executive and Leadership Team

Anthony Bihl, the Chief Executive Officer at Bioventus, directs the company's overarching strategy and operational execution. Bihl guides Bioventus in its mission to deliver innovations for active healing, ensuring the development and market introduction of products that meet the growing demand for effective, cost-efficient, and minimally invasive medical treatments. This leadership involves fostering a culture of innovation and driving the company's commitment to enhancing the body's natural healing capabilities. The Chief Executive Officer's strategic vision shapes the company's product pipeline and market penetration efforts across global healthcare landscapes. By focusing on clinically proven solutions, Anthony Bihl ensures Bioventus maintains its position as a leader in restorative therapies, directly impacting patient outcomes and the company's financial performance through disciplined execution and market expansion.

Mark Singleton, the Senior VP & Chief Financial Officer at Bioventus, manages all financial operations and strategic financial planning. Singleton oversees the fiscal health of the organization, ensuring robust financial controls and driving initiatives that support the company's growth objectives. This role involves managing capital allocation, investor relations, and financial reporting to stakeholders, aligning financial strategies with Bioventus's mission of active healing innovations. The Chief Financial Officer's expertise is critical in evaluating new product development, acquisition opportunities, and distribution agreements to ensure clinical effectiveness and cost efficiency. By optimizing financial performance, Mark Singleton directly contributes to the company's ability to bring advanced medical treatments to market, enhancing the body's natural healing processes and solidifying Bioventus's market leadership.

Helen Leupold, the Senior Vice President, Chief Human Resources Officer at Bioventus, leads all human capital strategies and organizational development initiatives. Leupold is responsible for cultivating a high-performance culture that supports Bioventus's commitment to innovation in active healing. This involves attracting, developing, and retaining top talent essential for bringing clinically effective, cost-efficient medical treatments to market. The Chief Human Resources Officer ensures that the company's workforce is aligned with its mission to enhance the body's natural healing processes. By fostering employee engagement and implementing robust HR policies, Helen Leupold drives organizational effectiveness and supports the strategic goals of Bioventus. This leadership ensures the company has the skilled personnel necessary to execute its product development, acquisition, and distribution strategies effectively.

Keith McBride, the Chief Technology Officer & Vice President, Research Development Pain & Restorative Therapies at Bioventus, spearheads technological innovation and research efforts. McBride directs the development of cutting-edge products designed for active healing, focusing on pain management and restorative therapies. This leadership role is crucial for bringing clinically effective, cost-efficient, and minimally invasive medical treatments to market, directly enhancing the body's natural healing processes. The Chief Technology Officer's oversight of research and development ensures Bioventus remains at the forefront of medical technology. By driving product innovation and managing the R&D pipeline, Keith McBride supports the company's strategic objectives and its mission to improve patient outcomes through advanced therapeutic solutions.